Multinational Comparison of SVF, PRP and BMAC in MSK

July 28, 2021

RegenMed is helping to coordinate a multi-national Circle to study the efficacy and safety of the use of platelet-rich plasma (PRP) and minimally manipulated cellular products (SVF and BMAC) for the treatment of various MSK pathologies. The initiative is spearheaded by Circle Founder, Maksim Alekseevich Strakhov, Associate Professor of the Department of Traumatology, Orthopedics and Military Field Surgery, Russian National Research Medical University, and will involve scientific and clinical collaborators from the Union State (Russia and Belarus), North America, EU, and various other regions.

Benefits of joining this Circle include:

  • Access to the inCytes™ platform in your native language, helping to automate the generation of relevant real-world data from your clinic;
  • Best practice patient privacy, storage, and encryption methodologies to protect personal information from yourself and patients;
  • Ability to aggregate and correlate, in a de-identified manner, data with your multi-national colleagues;
  • Participation in regular community events, whereby collaborators can review data, share protocols, and help standardize approaches across their medical practices.

Contact Us to Learn More or Participate

Read The Latest